Cargando…
Iminosugars: Promising therapeutics for influenza infection
Influenza virus causes three to five million severe respiratory infections per year in seasonal epidemics, and sporadic pandemics, three of which occurred in the twentieth century and are a continuing global threat. Currently licensed antivirals exclusively target the viral neuraminidase or M2 ion c...
Autores principales: | Tyrrell, Beatrice Ellen, Sayce, Andrew Cameron, Warfield, Kelly Lyn, Miller, Joanna Louise, Zitzmann, Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470110/ https://www.ncbi.nlm.nih.gov/pubmed/27931136 http://dx.doi.org/10.1080/1040841X.2016.1242868 |
Ejemplares similares
-
Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus
por: Miller, Joanna L., et al.
Publicado: (2018) -
Iminosugars counteract the downregulation of the interferon γ receptor by dengue virus
por: Miller, Joanna L., et al.
Publicado: (2019) -
Pathogen‐induced inflammation is attenuated by the iminosugar MON‐DNJ via modulation of the unfolded protein response
por: Sayce, Andrew C., et al.
Publicado: (2021) -
Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells
por: Perera, Nilanka, et al.
Publicado: (2022) -
Iminosugar antivirals: the therapeutic sweet spot
por: Alonzi, Dominic S., et al.
Publicado: (2017)